GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 141 filers reported holding GENMAB A/S in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,912 | -1.5% | 25,600 | +6.2% | 0.16% | -13.4% |
| Q2 2023 | $916,611 | +7.3% | 24,115 | +6.6% | 0.18% | -0.6% |
| Q1 2023 | $854,282 | -12.5% | 22,624 | -1.8% | 0.18% | -9.5% |
| Q4 2022 | $976,096 | -70.7% | 23,032 | -77.3% | 0.20% | -66.8% |
| Q1 2021 | $3,333,000 | -23.7% | 101,518 | -5.5% | 0.60% | -24.3% |
| Q4 2020 | $4,368,000 | +7.9% | 107,417 | -2.9% | 0.79% | -10.5% |
| Q3 2020 | $4,050,000 | +8.3% | 110,620 | +0.2% | 0.88% | -0.6% |
| Q2 2020 | $3,740,000 | +578.8% | 110,364 | +324.1% | 0.89% | +589.1% |
| Q1 2020 | $551,000 | -14.7% | 26,024 | -10.1% | 0.13% | +24.0% |
| Q4 2019 | $646,000 | – | 28,938 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |